Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-306818
Filing Date
2011-11-10
Accepted
2011-11-10 15:42:07
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d239106d10q.htm 10-Q 258595
2 SECTION 302 CEO CERTIFICATION d239106dex311.htm EX-31.1 6649
3 SECTION 302 CFO CERTIFICATION d239106dex312.htm EX-31.2 6686
4 SECTION 906 CEO CERTIFICATION d239106dex321.htm EX-32.1 3454
5 SECTION 906 CFO CERTIFICATION d239106dex322.htm EX-32.2 3508
  Complete submission text file 0001193125-11-306818.txt   1332853

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sclr-20110930.xml EX-101.INS 133874
7 XBRL TAXONOMY EXTENSION SCHEMA sclr-20110930.xsd EX-101.SCH 10201
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sclr-20110930_cal.xml EX-101.CAL 32421
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclr-20110930_lab.xml EX-101.LAB 110112
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclr-20110930_pre.xml EX-101.PRE 72683
Mailing Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011 4253681050
SCOLR Pharma, Inc. (Filer) CIK: 0000934936 (see all company filings)

EIN.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31982 | Film No.: 111195153
SIC: 2835 In Vitro & In Vivo Diagnostic Substances